ArticleNanomaterials (Basel, Switzerland)2024

Bimodal MRI/Fluorescence Nanoparticle Imaging Contrast Agent Targeting Prostate Cancer.

Hang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.